Tonge v. Novartis Pharmaceuticals Corporation
| Ronald Tonge |
| Novartis Pharmaceuticals Corporation |
| 2:2020cv00168 |
| March 12, 2020 |
| U.S. District Court for the Middle District of Florida |
| Sheri Polster Chappell |
| Nicholas P Mizell |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 23, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 14
ENDORSED ORDER granting #13 Novartis Pharmaceuticals Corporation's Motion for Leave to File a Reply in Support of its Motion to Dismiss or, in the Alternative, Motion for More Definite Statement. Defendant may file a reply, not to exceed six pages, to its #9 motion by May 12, 2020. Signed by Magistrate Judge Nicholas P. Mizell on 5/4/2020. (HAP)
|
| Filing 13 MOTION for Leave to file a Reply in support re #9 Motion to Dismiss Complaint or , MOTION for Miscellaneous Relief, specifically More Definite Statement by Novartis Pharmaceuticals Corporation. (Thomas, Michael) Motions referred to Magistrate Judge Nicholas P. Mizell. Modified on 5/5/2020 (MLJ). |
| Filing 12 NOTICE of hearing: Preliminary Pretrial Conference set for 6/4/2020 at 10:00 AM in Ft. Myers Courtroom 4 E before Magistrate Judge Nicholas P. Mizell. Parties shall file a Case Management Report on or before 5/28/2020.(WRW) |
| Filing 11 MEMORANDUM in opposition re #9 Motion to Dismiss filed by Ronald Tonge. (Osborne, Joseph) |
| Filing 10 CORPORATE Disclosure Statement re #5 Track Two Notice and Corporate Disclosure Order by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss Company, whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation.. (Thomas, Michael) |
| Filing 9 MOTION to Dismiss COMPLAINT or in the alternative MOTION for more definite statement and memorandum of law in support by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1)(Thomas, Michael) |
| Filing 8 NOTICE of pendency of related cases re #5 Track Two Notice and Corporate Disclosure Order per Local Rule 1.04(d) by Ronald Tonge. Related case(s): yes (Osborne, Joseph) |
| Filing 7 RETURN of service executed on 03/13/2020 by Ronald Tonge as to Novartis Pharmaceuticals Corporation. (Osborne, Joseph) |
| Filing 6 TRACK TWO NOTICE AND CORPORATE DISCLOSURE ORDER. Notice of pendency of other actions due by 4/3/2020. Signed by All Divisional Judges on 3/20/2020. (WRW) Double entry in error. |
| Filing 5 TRACK TWO NOTICE AND CORPORATE DISCLOSURE ORDER. Notice of pendency of other actions due by 4/3/2020. Signed by All Divisional Judges on 3/20/2020. (jmc) |
| Filing 4 POSSIBLE MDL Tag Along case for MDL, Information emailed to MDL Panel on 3/12/2020, including cover letter, copy of complaint, and docket sheet. (Attachments: #1 Complaint, #2 Docket Sheet) (MLJ) |
| Filing 3 SUMMONS issued as to Novartis Pharmaceuticals Corporation. (MLJ) |
| Filing 2 NEW CASE ASSIGNED to Judge Sheri Polster Chappell and Magistrate Judge Nicholas P. Mizell. New case number: 2:20-cv-168-FtM-38NPM. (SJB) |
| Filing 1 COMPLAINT against Novartis Pharmaceuticals Corporation with Jury Demand (Filing fee $ 400 receipt number 113A-16586142) filed by RONALD TONGE. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons)(Osborne, Joseph) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Tonge v. Novartis Pharmaceuticals Corporation | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Novartis Pharmaceuticals Corporation | |
| Represented By: | Jacqueline A.R. Root |
| Represented By: | Michael J. Thomas |
| Represented By: | Kathryn L. Hood |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Ronald Tonge | |
| Represented By: | Joseph A. Osborne |
| Represented By: | James Robert Bell |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
